←Back to structures
CAKLQF020000019.1__CAH1089794.1__SAMEA5780031_03096__00060
Bact-VirCAKLQF020000019.1__CAH1089794.1__SAMEA5780031_03096__00060
Identity
- Kingdom:
- phage
Quality
67.7
mean pLDDT
Cluster
Singleton — not in a non-trivial cluster
3D Structure
Domains
high = three domain segmentations agree, medium = two domain segmentations agree. Numbered high-first then medium, N→C within each tier.
D1
high
residues 210-324
Domain cluster:
rep: S2_012_000_R2_scaffold_0_prodigal-single.1__X__X__01041__D28-149
Pfam (1)
| Accession | Name | Score | E-value | Q cov | HMM cov |
|---|---|---|---|---|---|
| PF04280.22 best | Tim44 | 47.9 | 2.20e-12 | 100.0% | 88.5% |
CATH (70)
| Domain ID | Class ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 1jkgA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.77 | 72.0 | 6.68e-01 | 100.0% | 88.5% |
| 3ef8A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.74 | 69.0 | 6.30e-01 | 100.0% | 84.5% |
| 7c5yA02 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.74 | 68.0 | 6.16e-01 | 100.0% | 99.3% |
| 3e99A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.74 | 67.0 | 6.17e-01 | 100.0% | 89.2% |
| 1idpA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.73 | 67.0 | 6.18e-01 | 100.0% | 93.9% |
| 3soyA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.73 | 67.0 | 6.26e-01 | 100.0% | 90.1% |
| 3robA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.73 | 68.0 | 6.46e-01 | 100.0% | 93.9% |
| 2rfrA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.73 | 67.0 | 6.02e-01 | 100.0% | 81.8% |
| 3ejvA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.72 | 66.0 | 5.91e-01 | 99.1% | 94.3% |
| 5ig0A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.72 | 66.0 | 6.37e-01 | 100.0% | 94.7% |
| 3mg1B02 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.72 | 66.0 | 6.38e-01 | 97.4% | 90.4% |
| 3bb9B00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.72 | 66.0 | 6.44e-01 | 100.0% | 96.8% |
| 4l8oA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.72 | 66.0 | 5.82e-01 | 100.0% | 76.2% |
| 3fsdA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.72 | 65.0 | 6.42e-01 | 98.3% | 96.7% |
| 3gwrB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.72 | 65.0 | 6.31e-01 | 98.3% | 92.9% |
| 2r4iA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.71 | 66.0 | 6.44e-01 | 100.0% | 94.3% |
| 3d9rB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.71 | 65.0 | 6.21e-01 | 100.0% | 93.2% |
| 2b1xB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.71 | 64.0 | 5.69e-01 | 100.0% | 87.4% |
| 1of5A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.71 | 64.0 | 5.84e-01 | 100.0% | 81.8% |
| 3kspA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.71 | 65.0 | 6.27e-01 | 100.0% | 92.2% |
| 4gb5A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.70 | 64.0 | 5.91e-01 | 100.0% | 90.5% |
| 3gzbA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.70 | 65.0 | 5.86e-01 | 100.0% | 79.9% |
| 3hx8A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.69 | 63.0 | 6.09e-01 | 99.1% | 95.3% |
| 3fkaB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.69 | 63.0 | 6.23e-01 | 100.0% | 95.0% |
| 5cxoB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.68 | 63.0 | 5.99e-01 | 100.0% | 86.6% |
| 3rgaA01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.68 | 62.0 | 5.92e-01 | 98.3% | 88.7% |
| 4ccvA00 | 3.10.450.10 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.68 | 52.0 | 5.25e-01 | 100.0% | 80.9% |
| 3f9sB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.68 | 63.0 | 5.84e-01 | 100.0% | 88.7% |
| 3ebyA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.68 | 61.0 | 5.56e-01 | 100.0% | 89.5% |
| 3hzpA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.67 | 61.0 | 5.91e-01 | 100.0% | 91.3% |
| 4j8tA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.67 | 61.0 | 5.87e-01 | 98.3% | 92.2% |
| 1tuhA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.67 | 61.0 | 5.82e-01 | 98.3% | 90.1% |
| 2kxgA00 | 3.10.450.10 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.66 | 46.0 | 4.97e-01 | 100.0% | 86.3% |
| 2bngC00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.66 | 58.0 | 5.43e-01 | 100.0% | 78.6% |
| 3blzA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.66 | 60.0 | 5.84e-01 | 100.0% | 93.5% |
| 5aigA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.65 | 58.0 | 5.64e-01 | 98.3% | 89.5% |
| 3a76A01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.65 | 59.0 | 5.53e-01 | 100.0% | 88.5% |
| 3ff2A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.65 | 59.0 | 5.88e-01 | 98.3% | 96.6% |
| 3dmcA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.65 | 59.0 | 5.59e-01 | 100.0% | 91.8% |
| 7f13A01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.65 | 59.0 | 5.48e-01 | 100.0% | 81.2% |
| 1nu3A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.64 | 58.0 | 5.36e-01 | 100.0% | 81.4% |
| 2k54A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.64 | 56.0 | 5.50e-01 | 100.0% | 90.2% |
| 1s5aB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.63 | 57.0 | 5.34e-01 | 100.0% | 84.6% |
| 2gexA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.63 | 57.0 | 5.26e-01 | 100.0% | 82.9% |
| 3grdA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.63 | 57.0 | 5.41e-01 | 98.3% | 89.4% |
| 3dm8A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.62 | 56.0 | 5.31e-01 | 99.1% | 90.4% |
| 3kkgA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.62 | 56.0 | 5.22e-01 | 100.0% | 88.2% |
| 4h3uA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.62 | 54.0 | 5.24e-01 | 99.1% | 86.2% |
| 3ehcB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.62 | 55.0 | 5.34e-01 | 99.1% | 89.8% |
| 3ec9A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.61 | 56.0 | 5.42e-01 | 100.0% | 89.9% |
| 3ebtA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.61 | 55.0 | 5.28e-01 | 100.0% | 90.8% |
| 4akrA02 | 3.90.1150.210 | Alpha Beta › Alpha-Beta Complex › Aspartate Aminotransferase, domain 1 › F-actin capping protein, beta subunit | 0.61 | 39.0 | 3.65e-01 | 100.0% | 51.0% |
| 3hk4A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.61 | 55.0 | 5.45e-01 | 100.0% | 94.1% |
| 1di2A00 | 3.30.160.20 | Alpha Beta › 2-Layer Sandwich › Double Stranded RNA Binding Domain › | 0.59 | 33.0 | 4.19e-01 | 91.3% | 91.3% |
| 2gtlN02 | 2.40.128.620 | Mainly Beta › Beta Barrel › Lipocalin › | 0.59 | 42.0 | 3.72e-01 | 100.0% | 50.0% |
| 4lgqA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.59 | 52.0 | 5.04e-01 | 100.0% | 90.2% |
| 3f14A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.58 | 50.0 | 5.14e-01 | 100.0% | 97.3% |
| 4dduA07 | 2.60.510.20 | Mainly Beta › Sandwich › EV matrix protein fold › | 0.56 | 37.0 | 3.82e-01 | 91.3% | 71.0% |
| 2rckA01 | 3.15.10.30 | Alpha Beta › Super Roll › Bactericidal permeability-increasing protein; domain 1 › TULIP domain | 0.56 | 50.0 | 4.06e-01 | 100.0% | 61.5% |
| 1bp1A01 | 3.15.10.10 | Alpha Beta › Super Roll › Bactericidal permeability-increasing protein; domain 1 › Bactericidal permeability-increasing protein; domain 1 | 0.55 | 50.0 | 4.28e-01 | 100.0% | 67.8% |
| 1sjwA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.55 | 49.0 | 4.59e-01 | 100.0% | 84.5% |
| 3h4zB03 | 3.15.10.50 | Alpha Beta › Super Roll › Bactericidal permeability-increasing protein; domain 1 › | 0.54 | 50.0 | 4.20e-01 | 100.0% | 68.6% |
| 1h2iA01 | 3.30.390.80 | Alpha Beta › 2-Layer Sandwich › Enolase-like; domain 1 › DNA repair protein Rad52/59/22 | 0.53 | 41.0 | 3.83e-01 | 82.6% | 70.3% |
| 3fzxA00 | 2.40.360.20 | Mainly Beta › Beta Barrel › YmcC-like fold › | 0.53 | 47.0 | 3.86e-01 | 97.4% | 91.0% |
| 1lyvA00 | 3.90.190.10 | Alpha Beta › Alpha-Beta Complex › Protein-Tyrosine Phosphatase; Chain A › Protein tyrosine phosphatase superfamily | 0.53 | 42.0 | 3.11e-01 | 82.6% | 57.2% |
| 1blwA02 | 2.60.40.10 | Mainly Beta › Sandwich › Immunoglobulin-like › Immunoglobulins | 0.53 | 30.0 | 3.18e-01 | 99.1% | 61.8% |
| 1ut7B01 | 2.170.150.80 | Mainly Beta › Beta Complex › Metal Binding Protein, Guanine Nucleotide Exchange Factor; Chain A › NAC domain | 0.52 | 41.0 | 4.02e-01 | 92.2% | 77.6% |
| 4q0yA00 | 2.60.40.4400 | Mainly Beta › Sandwich › Immunoglobulin-like › | 0.51 | 40.0 | 3.85e-01 | 100.0% | 73.3% |
| 3bf2A00 | 3.30.160.150 | Alpha Beta › 2-Layer Sandwich › Double Stranded RNA Binding Domain › Lipoprotein like domain | 0.51 | 42.0 | 4.16e-01 | 93.0% | 84.0% |
| 3fidA00 | 2.40.128.140 | Mainly Beta › Beta Barrel › Lipocalin › Outer membrane protein | 0.51 | 43.0 | 3.28e-01 | 95.7% | 75.7% |
ECOD (83)
| UID | F-ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 3971296 | 243.1.1.5 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Tim44 | 0.91 | 88.0 | 8.39e-01 | 100.0% | 89.9% |
| 3700510 | 243.1.1.94 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF26532 | 0.87 | 82.0 | 6.68e-01 | 100.0% | 76.0% |
| 3597592 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.86 | 82.0 | 6.56e-01 | 100.0% | 74.1% |
| 3182613 | 243.1.1.44 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › MBA1 | 0.85 | 81.0 | 6.32e-01 | 100.0% | 57.3% |
| 4254866 | 243.1.1.66 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › TcaA_5th | 0.79 | 74.0 | 7.17e-01 | 100.0% | 92.0% |
| 3952458 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.79 | 74.0 | 7.08e-01 | 100.0% | 88.5% |
| 1558628 | 243.1.1.15 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › T4BSS_DotI_IcmL | 0.79 | 73.0 | 6.79e-01 | 100.0% | 93.6% |
| 3962739 | 243.1.1.77 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF29518 | 0.78 | 72.0 | 6.54e-01 | 100.0% | 80.0% |
| 3961892 | 243.1.1.77 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF29518 | 0.77 | 71.0 | 6.62e-01 | 100.0% | 89.3% |
| 3941713 | 243.1.1.6 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › VirB8 | 0.76 | 71.0 | 6.59e-01 | 100.0% | 97.9% |
| 3291726 | 243.1.1.77 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF29518 | 0.76 | 71.0 | 6.37e-01 | 100.0% | 78.6% |
| 3517998 | 243.1.1.40 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NXF_NTF2 | 0.76 | 70.0 | 5.78e-01 | 100.0% | 81.5% |
| 3959534 | 243.1.1.77 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF29518 | 0.76 | 70.0 | 6.64e-01 | 100.0% | 88.9% |
| 3588474 | 243.1.1.17 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › TpcC | 0.76 | 70.0 | 6.95e-01 | 100.0% | 96.7% |
| None | — | 0.75 | 70.0 | 6.96e-01 | 100.0% | 96.7% | |
| 3958251 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.75 | 69.0 | 6.25e-01 | 100.0% | 77.9% |
| 3957821 | 243.1.1.77 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF29518 | 0.75 | 69.0 | 6.69e-01 | 100.0% | 93.8% |
| 3958465 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.75 | 68.0 | 6.21e-01 | 98.3% | 79.3% |
| 3828738 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.75 | 69.0 | 6.23e-01 | 100.0% | 80.6% |
| 3407993 | 243.1.1.40 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NXF_NTF2 | 0.75 | 69.0 | 5.90e-01 | 100.0% | 82.2% |
| 3974899 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.75 | 70.0 | 6.39e-01 | 100.0% | 89.0% |
| 3288890 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.74 | 68.0 | 6.55e-01 | 99.1% | 91.5% |
| 4152363 | 243.1.1.115 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF29733 | 0.74 | 68.0 | 6.69e-01 | 100.0% | 93.5% |
| 4189419 | 243.1.1.77 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF29518 | 0.74 | 68.0 | 6.21e-01 | 100.0% | 80.0% |
| 3281242 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.74 | 68.0 | 6.54e-01 | 100.0% | 94.6% |
| 3430924 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.74 | 68.0 | 6.04e-01 | 100.0% | 76.9% |
| 3970236 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.73 | 68.0 | 6.36e-01 | 100.0% | 88.5% |
| 4676601 | 243.1.1.1 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Ring_hydroxyl_B | 0.73 | 67.0 | 5.88e-01 | 100.0% | 86.4% |
| 3432106 | 243.3.1.19 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › DUF3615 | 0.73 | 53.0 | 5.25e-01 | 100.0% | 71.3% |
| 4950139 | 243.1.1.25 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_3 | 0.73 | 67.0 | 6.57e-01 | 100.0% | 96.0% |
| 143237 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.73 | 68.0 | 6.46e-01 | 100.0% | 93.9% |
| 3940802 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.73 | 55.0 | 5.76e-01 | 100.0% | 86.7% |
| 3970009 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.73 | 67.0 | 5.83e-01 | 100.0% | 82.8% |
| 3056323 | 243.1.1.1 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Ring_hydroxyl_B | 0.73 | 67.0 | 5.98e-01 | 100.0% | 88.6% |
| 3278323 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.73 | 68.0 | 6.49e-01 | 100.0% | 91.5% |
| 3290399 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.72 | 66.0 | 6.23e-01 | 100.0% | 86.3% |
| 4927181 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.72 | 67.0 | 6.45e-01 | 100.0% | 95.3% |
| 3281901 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.72 | 66.0 | 6.07e-01 | 100.0% | 86.9% |
| 6405 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.72 | 66.0 | 6.27e-01 | 100.0% | 91.7% |
| 3839915 | 243.1.1.6 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › VirB8 | 0.72 | 65.0 | 6.14e-01 | 100.0% | 92.1% |
| 6389 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.71 | 66.0 | 6.46e-01 | 100.0% | 95.1% |
| 5002369 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.71 | 63.0 | 6.33e-01 | 100.0% | 95.7% |
| 137634 | 243.1.1.25 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_3 | 0.71 | 65.0 | 6.27e-01 | 100.0% | 92.2% |
| 3698353 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.71 | 64.0 | 6.27e-01 | 99.1% | 98.4% |
| 6390 | 243.1.1.25 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_3 | 0.70 | 63.0 | 6.28e-01 | 97.4% | 99.2% |
| 3725114 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.70 | 64.0 | 5.92e-01 | 100.0% | 85.5% |
| 5009713 | 243.1.1.1 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Ring_hydroxyl_B | 0.70 | 63.0 | 5.69e-01 | 100.0% | 92.5% |
| 4960252 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.70 | 62.0 | 6.18e-01 | 96.5% | 95.0% |
| 5003871 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.70 | 64.0 | 5.99e-01 | 100.0% | 95.0% |
| 3587514 | 243.1.1.17 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › TpcC | 0.70 | 64.0 | 6.19e-01 | 100.0% | 90.8% |
| 2765234 | 243.3.1.12 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › SQAPI | 0.70 | 50.0 | 5.34e-01 | 96.5% | 87.6% |
| 3281675 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.70 | 58.0 | 6.03e-01 | 89.6% | 100.0% |
| 4884000 | 243.1.1.1 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Ring_hydroxyl_B | 0.69 | 61.0 | 5.55e-01 | 97.4% | 91.0% |
| 3764790 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.69 | 51.0 | 5.59e-01 | 100.0% | 93.7% |
| 3291354 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.69 | 62.0 | 5.24e-01 | 99.1% | 63.2% |
| 3963115 | 243.1.1.77 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF29518 | 0.69 | 62.0 | 5.73e-01 | 100.0% | 83.4% |
| 3458604 | 243.3.1.19 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › DUF3615 | 0.69 | 44.0 | 5.26e-01 | 87.0% | 100.0% |
| 3591282 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.68 | 61.0 | 6.10e-01 | 98.3% | 97.5% |
| 3278986 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.68 | 61.0 | 5.56e-01 | 100.0% | 79.4% |
| 3937044 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.68 | 49.0 | 5.30e-01 | 100.0% | 90.5% |
| 3959349 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.68 | 62.0 | 5.86e-01 | 98.3% | 88.8% |
| 3287863 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.68 | 61.0 | 5.87e-01 | 97.4% | 89.2% |
| 3489888 | 881.1.1.2 ↗ | a+b three layers › Mog1p/PsbP-like › Mog1p/PsbP-like › Mog1p/PsbP-like › Mog1 | 0.67 | 48.0 | 4.32e-01 | 99.1% | 53.1% |
| 3230449 | 243.1.1.82 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF26529 | 0.67 | 61.0 | 5.55e-01 | 100.0% | 83.9% |
| 3255190 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.67 | 52.0 | 5.47e-01 | 99.1% | 92.1% |
| 4940463 | 274.1.1.0 ↗ | a+b two layers › Pili subunits › Pili subunits › Pili subunits | 0.67 | 40.0 | 3.84e-01 | 100.0% | 51.1% |
| 3241166 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.66 | 55.0 | 5.01e-01 | 100.0% | 67.3% |
| 3226411 | 243.1.1.82 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF26529 | 0.65 | 59.0 | 5.41e-01 | 100.0% | 93.3% |
| 3959285 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.65 | 46.0 | 5.20e-01 | 76.5% | 100.0% |
| 169779 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.65 | 59.0 | 5.88e-01 | 98.3% | 96.6% |
| 3696055 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.65 | 58.0 | 5.53e-01 | 98.3% | 87.4% |
| 3287916 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.64 | 58.0 | 5.55e-01 | 100.0% | 90.0% |
| 134348 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.63 | 56.0 | 5.40e-01 | 98.3% | 88.0% |
| 2635091 | 9.1.1.0 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins | 0.62 | 46.0 | 3.96e-01 | 100.0% | 48.6% |
| 3947973 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.62 | 54.0 | 5.33e-01 | 98.3% | 90.4% |
| 3750494 | 883.1.1.0 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like | 0.58 | 54.0 | 4.41e-01 | 100.0% | 59.5% |
| 3708657 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.56 | 48.0 | 4.60e-01 | 95.7% | 91.9% |
| 3389219 | 206.1.1.55 ↗ | a+b complex topology › Protein kinase/SAICAR synthase/ATP-grasp › Protein kinase/SAICAR synthase/ATP-grasp › Protein kinase › EcKL | 0.55 | 50.0 | 3.39e-01 | 100.0% | 34.7% |
| 3391752 | 206.1.1.55 ↗ | a+b complex topology › Protein kinase/SAICAR synthase/ATP-grasp › Protein kinase/SAICAR synthase/ATP-grasp › Protein kinase › EcKL | 0.53 | 48.0 | 3.28e-01 | 100.0% | 30.6% |
| 5052250 | 12.3.1.15 ↗ | beta sandwiches › Glycosyl hydrolase domain-like › supersandwich › supersandwich › AmyA-gluTrfs_C | 0.53 | 48.0 | 3.60e-01 | 100.0% | 54.7% |
| 3875620 | 883.1.1.1 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like › LBP_BPI_CETP | 0.53 | 48.0 | 4.08e-01 | 100.0% | 70.5% |
| 4445572 | 4099.1.1.22 ↗ | a+b two layers › Kinetochore globular domain-like › Kinetochore globular domain-like › Kinetochore globular domain-like › CENP-P | 0.51 | 39.0 | 3.78e-01 | 98.3% | 70.8% |
| 3715923 | 5.1.3.28 ↗ | beta duplicates or obligate multimers › beta-propeller-like › beta-propeller › 6-bladed › BNR_3 | 0.51 | 46.0 | 3.14e-01 | 100.0% | 28.8% |